ORBIS BIOSCIENCES INC has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are MSM INNOVATIONS INC, AZANTA AS and DING WUPEI.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 3 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Berkland Cory | 22 |
#2 | Singh Milind | 12 |
#3 | Dormer Nathan | 11 |
Publication | Filing date | Title |
---|---|---|
CN109414401A | Biodegradable polymer microsphere composition for parenteral | |
CA2951905A1 | Extended-release drug delivery compositions | |
EP3110403A1 | Taste masking drug formulations | |
WO2014205228A1 | Tramadol particle formulations and methods | |
CA2859174A1 | Sustained release particle formulations | |
WO2013090439A1 | Sustained release particle formulations of guaifenesin |